Herb Vloedman - SIGA Technologies Senior Officer
| SIGA Stock | USD 10.46 0.07 0.67% |
Executive
Herb Vloedman is Senior Officer of SIGA Technologies
| Address | 31 East 62nd Street, New York, NY, United States, 10065 |
| Phone | 212 672 9100 |
| Web | https://www.siga.com |
SIGA Technologies Management Efficiency
The company has return on total asset (ROA) of 0.2326 % which means that it generated a profit of $0.2326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3709 %, meaning that it created $0.3709 on every $100 dollars invested by stockholders. SIGA Technologies' management efficiency ratios could be used to measure how well SIGA Technologies manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.28. The current year's Return On Capital Employed is expected to grow to 0.44. At present, SIGA Technologies' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 23.1 M, whereas Non Currrent Assets Other are forecasted to decline to about 2 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Lisa Price | Deciphera Pharmaceuticals LLC | N/A | |
| MD FAAFP | Collegium Pharmaceutical | 63 | |
| Tiffany MBA | Esperion Therapeutics | N/A | |
| Christopher MD | Collegium Pharmaceutical | N/A | |
| Ingrid Delaet | Neurocrine Biosciences | 57 | |
| Daniel Martin | Deciphera Pharmaceuticals LLC | 49 | |
| Umesh Mahajan | Silver Spike Investment | 53 | |
| Archana Bhaskar | Dr Reddys Laboratories | 53 | |
| Michael MD | Ironwood Pharmaceuticals | 64 | |
| Eric Benevich | Neurocrine Biosciences | 59 | |
| Mark Elrod | Avadel Pharmaceuticals PLC | N/A | |
| Lisa Evoli | Catalent | 54 | |
| David Boyer | Neurocrine Biosciences | 44 | |
| Angie Woods | Avadel Pharmaceuticals PLC | N/A | |
| Samuel Parisi | Alkermes Plc | 49 | |
| Jeffrey JD | Deciphera Pharmaceuticals LLC | N/A | |
| Glenn David | Phibro Animal Health | 51 | |
| Benjamin Looker | Esperion Therapeutics | 42 | |
| Matthew Abernethy | Neurocrine Biosciences | 44 | |
| Mike Nanfito | Ironwood Pharmaceuticals | N/A | |
| Max Reinhardt | Pacira Pharmaceuticals | 53 | |
Management Performance
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.23 |
SIGA Technologies Leadership Team
Elected by the shareholders, the SIGA Technologies' board of directors comprises two types of representatives: SIGA Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SIGA. The board's role is to monitor SIGA Technologies' management team and ensure that shareholders' interests are well served. SIGA Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SIGA Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jay MD, Chief VP | ||
| Tove Bolken, Senior Officer | ||
| Herb Vloedman, Senior Officer | ||
| III MD, CEO Director | ||
| JD Esq, General Counsel | ||
| Dennis Hruby, Chief Scientific Officer and VP | ||
| Daniel Luckshire, CFO, Principal Accounting Officer, Executive VP and Secretary | ||
| Diem MBA, CEO Director |
SIGA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SIGA Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.23 | ||||
| Profit Margin | 0.49 % | ||||
| Operating Margin | 0.79 % | ||||
| Current Valuation | 589.4 M | ||||
| Shares Outstanding | 71.12 M | ||||
| Shares Owned By Insiders | 43.09 % | ||||
| Shares Owned By Institutions | 49.32 % | ||||
| Number Of Shares Shorted | 4.95 M | ||||
| Price To Earning | 12.41 X |
Currently Active Assets on Macroaxis
When determining whether SIGA Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SIGA Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Siga Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Siga Technologies Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SIGA Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For information on how to trade SIGA Stock refer to our How to Trade SIGA Stock guide.Note that the SIGA Technologies information on this page should be used as a complementary analysis to other SIGA Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for SIGA Stock analysis
When running SIGA Technologies' price analysis, check to measure SIGA Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIGA Technologies is operating at the current time. Most of SIGA Technologies' value examination focuses on studying past and present price action to predict the probability of SIGA Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIGA Technologies' price. Additionally, you may evaluate how the addition of SIGA Technologies to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is SIGA Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SIGA Technologies. If investors know SIGA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SIGA Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.721 | Earnings Share 0.95 | Revenue Per Share 1.961 | Quarterly Revenue Growth 9.255 | Return On Assets 0.2326 |
The market value of SIGA Technologies is measured differently than its book value, which is the value of SIGA that is recorded on the company's balance sheet. Investors also form their own opinion of SIGA Technologies' value that differs from its market value or its book value, called intrinsic value, which is SIGA Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SIGA Technologies' market value can be influenced by many factors that don't directly affect SIGA Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SIGA Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if SIGA Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SIGA Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.